Centessa Pharmaceuticals PLC
CNTA
Company Profile
Business description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Contact
1 Ashley Road
3rd Floor
Altrincham
CheshireWA14 2DT
GBRSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
98
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,046.80 | 59.50 | -0.65% |
| CAC 40 | 7,872.02 | 41.91 | 0.54% |
| DAX 40 | 23,611.33 | 84.28 | 0.36% |
| Dow JONES (US) | 46,292.78 | 88.76 | -0.19% |
| FTSE 100 | 9,223.32 | 3.36 | -0.04% |
| HKSE | 26,385.39 | 226.27 | 0.86% |
| NASDAQ | 22,573.47 | 215.50 | -0.95% |
| Nikkei 225 | 45,349.79 | 143.87 | -0.32% |
| NZX 50 Index | 13,129.79 | 6.75 | -0.05% |
| S&P 500 | 6,656.92 | 36.83 | -0.55% |
| S&P/ASX 200 | 8,756.60 | 58.40 | -0.66% |
| SSE Composite Index | 3,845.91 | 24.08 | 0.63% |